WAVE.V -- Bottoming Out Undervalued Pharma/COVID-19 PlayThe most attractive part of WAVE.V is share structure: 54M total float with 41M shares held by insiders / escrowed, leaving about 13M shares free trading. The company owns a portfolio of generic oncology drugs from which it generates over $300K of quarterly revenue. $1M in cash on hand. Based on las
−0.0140EUR
−457.73 KEUR
859.41 KEUR
13.61 M
About WAVERLEY PHARMA INC
Sector
CEO
Larry Thiessen
Headquarters
Winnipeg
Website
Founded
2014
FIGI
BBG00X9DLZ62
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
WAVE.V -- Pharma company offering oncology/COVID-19 drugsBig jump in this little known Canadian pharma's stock price this morning on news of market authorization of their drugs in multiple European countries. Tiny float makes for big moves up and down. Good speculative buy on pullback in the .20s, IMO.
Waverley Pharma Announces Grant of Market Authorizat
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange WAVERLEY PHARMA INC. stocks are traded under the ticker 5GZ.
Yes, you can track WAVERLEY PHARMA INC. financials in yearly and quarterly reports right on TradingView.
5GZ net income for the last quarter is −215.84 K EUR, while the quarter before that showed −166.66 K EUR of net income which accounts for −29.51% change. Track more WAVERLEY PHARMA INC. financial stats to get the full picture.
No, 5GZ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 5GZ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade WAVERLEY PHARMA INC. stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. WAVERLEY PHARMA INC. EBITDA is −513.29 K EUR, and current EBITDA margin is −42.54%. See more stats in WAVERLEY PHARMA INC. financial statements.